News & Updates

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022 byStephen Padilla

In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022
Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer
Cell-cycle progression tied to metastasis-free survival in high-risk prostate cancer
17 Nov 2022
Depressive symptoms implicated in lung cancer via smoking habits
Depressive symptoms implicated in lung cancer via smoking habits
16 Nov 2022

Individuals with greater depressive symptoms are at risk of developing lung cancer, with the association directly and indirectly attributed to smoking habits, as reported in a study.

Depressive symptoms implicated in lung cancer via smoking habits
16 Nov 2022
Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes
Pretreatment sarcopenic assessments help predict gynaecologic cancer outcomes
15 Nov 2022